This inventor holds 1 USPTO granted patent. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Kouichi Kaidoh and Pharmaceutical Innovation
Introduction
Kouichi Kaidoh is an inventor associated with Kissei Pharmaceutical Co., Ltd. in Azumino, Japan. His patent work concerns a potential treatment for interstitial cystitis, a condition that can involve bladder pain and urinary symptoms.
Latest Patents
Kaidoh is named on 1 patent, titled “Agent for Treating Interstitial Cystitis.” The invention describes an agent containing a phenoxyacetic acid derivative, or a pharmacologically acceptable salt of that derivative. The patent states that the compound has selective β-adrenoceptor-stimulating activity and can inhibit capsaicin-sensitive sensory nerves.
The proposed applications include prevention or treatment of interstitial cystitis and overactive bladder accompanied by pain. The patent also discusses potential relevance to other conditions involving capsaicin-sensitive sensory nerves, including pain and inflammation, as well as irritable bowel syndrome.
Career Highlights
Kaidoh’s listed patent reflects pharmaceutical research focused on the biological mechanisms associated with bladder pain and related disorders. His work is connected with Kissei Pharmaceutical Co., Ltd., a pharmaceutical company based in Japan.
Collaborations
Satoshi Akahane is identified as Kaidoh’s coworker in connection with the information provided. The patent’s development reflects collaborative research within a pharmaceutical setting.
Conclusion
Kouichi Kaidoh’s patent documents a proposed pharmaceutical approach to interstitial cystitis and related conditions, highlighting his contribution to research at Kissei Pharmaceutical Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile